Novo Nordisk receives U.S. FDA clearance for the NovoPen Echo

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
First insulin injection device to combine half-unit dosing with a memory function to help patients better manage their diabetes

PLAINSBORO, N.J., Aug. 21, 2013 /PRNewswire via COMTEX/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the insulin device NovoPen Echo?. This marks the first and only pen device in the U.S. with half-unit dosing and a memory function that records the dose and time passed since the last injection.

http://www.marketwatch.com/story/no...ulin-injection-device-novopen-echo-2013-08-21

The Yanks always seem to be behind us in getting such things approved - I've had an Echo for ages!
 
Status
Not open for further replies.
Back
Top